Tellurian is selling its upstream assets to a company that will support its Driftwood project. Tellurian (TELL -10.31%) has struggled mightily in recent years. Falling natural gas prices and surging interest rates have had a significant impact on its plan to build an integrated natural gas production and export business. Those issues have weighed heavily on its stock, which is down more than 90% from its peak in 2022. However, Tellurian is finally making some progress on its turnaround plan. It has agreed t ...

Initiatives like the CHIPS Act are already having a tremendous impact.For the first time in a long while, the United States is serious about increasing domestic semiconductor ("chip") manufacturing. For years, the U.S. has been hyper-reliant on Taiwan for chip production; however, the threat that China will seek to reunify with the island, potentially by force, makes this a massive economic risk.Because of this, the U.S. introduced the CHIPS and Science Act, which provides monetary incentives to companies t ...

Parkev Tatevosian, CFA has positions in Chipotle Mexican Grill. The Motley Fool has positions in and recommends Chipotle Mexican Grill. The Motley Fool has a disclosure policy.Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool. ...

The past few years have been the exception to the norm rather than the norm. A shakeup could be brewing.Even investors who only keep casual tabs on the stock market probably know most of its recent gains have been driven by Nasdaq-listed stocks such as Microsoft and Nvidia. Indeed, all seven of the so-called "Magnificent Seven" stocks leading the charge throughout the past few years are Nasdaq names. This dynamic makes an exchange-traded fund (ETF) like the Invesco QQQ Trust (QQQ -0.70%) a compelling prospe ...

Vertex might not present a clear and present danger to Abbott and DexCom but could present a clear future threat.Successful investors think about the future by focusing on what the new opportunities might be. They also pay attention to threats that could emerge that might impact the stocks they own. Sometimes, those threats come out of the blue, but other times, they're identifiable well in advance.If you own shares of Abbott (ABT -1.20%) or DexCom (DXCM 0.20%), there's a looming threat to know about. It's ...

The oil industry's merger wave continues.A consolidation wave continues to wash over the oil patch. ExxonMobil kicked off the current boom in mergers and acquisitions last year with its recently closed $60 billion deal for Pioneer Natural Resources. Rival Chevron followed with its acquisition of Hess, which it hopes to close in the coming months. The sector has seen several smaller transactions as oil companies pair up to enhance their positions and reduce costs. The latest industry tie-up will see ConocoPh ...

UiPath股票分析 - UiPath股票(PATH)当前处于历史最低价位 [1] - 股票在2024年5月29日交易中下跌2.40% [1] - 尽管财报表现超预期(双beat)，股价仍大幅下挫 [1] 财报与市场表现 - 视频发布于2024年5月30日，分析近期财报 [1] - 使用数据来自2024年5月29日交易日 [1]

Starbucks is trading near 52-week lows, but is that a sign of value or trouble for the coffee giant?Starbucks (SBUX -0.77%) has been through turbulent times before as consumer tastes change but this time may be different. The company's place as a daily go-to isn't the same with more people working from home and online ordering isn't the same as the Starbucks experience. Travis Hoium covers the opportunity and threat for investors in this video.*Stock prices used were end-of-day prices of May 29, 2024. The v ...

Here's one of the big bright spots from recent financial results.Whenever I write about cloud-based data company Snowflake (SNOW -1.69%), I try to do so with plenty of nuance. It's a complex business with a lot to consider. I don't want to downplay the good but I don't want to overlook the bad either -- both sides must be considered to make a confident investment decision.On May 22, Snowflake reported financial results for its fiscal first quarter of 2025. The report contained some bullish news that some mi ...

文章核心观点 - 英伟达持有纳米-X影像公司股票，但这并不意味着该股票适合普通投资者 纳米-X影像公司虽有技术优势，但尚未将产品转化为可持续业务，在实现盈利前建议观望而非买入 [1][11] 纳米-X影像公司股价表现 - 过去12个月纳米-X影像公司股价下跌约53% [1] 买入纳米-X影像公司股票的理由 - Nanox.ARC采用专有技术，产生X射线所需电力少，可降低成像成本 该设备目前供专业医疗设施的放射科医生使用，理论上可用于更多场景 [3][4] - 公司推出的Nanox.AI产品套件，可利用人工智能识别慢性病患者，能提高三维成像服务在放射科医生短缺地区的可及性 [5] 避免买入纳米-X影像公司股票的理由 - 公司试图重塑医疗影像模式未得到医疗服务提供商认可 2024年第一季度总收入同比仅增长4%，至255万美元 [6] - 第一季度成像设备销售额仅4.8万美元，2021年收购的人工智能解决方案收入仅9.7万美元，毛亏损200万美元 关闭该人工智能解决方案每年可节省约800万美元 [7] - 第一季度亏损超1200万美元，截至3月底现金仅4490万美元 若管理层不能尽快改善状况，可能通过稀释股权的方式筹集资金，使长期股东难以获利 [8] 关于英伟达持股 - 英伟达是人工智能应用半导体的领先制造商 其持有纳米-X影像公司股票并非直接认可该公司的人工智能相关业务 2017年英伟达投资斑马医疗，2021年纳米-X影像公司通过换股方式收购斑马医疗 [9] - 英伟达未在收购后出售纳米-X影像公司股票，但持股规模小，英伟达市值约27万亿美元，其持有的纳米-X影像公司股票价值低于加州一套普通三居室房屋 [10]